Evidence map›Paper›PMID 39812712›Full record

ArticleArchives of osteoporosis2025

Patient perceptions of osteoporosis management: a qualitative pilot study by a patient advisory group.

R M Javier, F Debiais, F Alliot-Launois, D Poivret, P Bosgiraud, F Barbe, M Bouyssié, M Devert, F Roux, M P Sacchi and 5 more

Abstract read
In one paragraph

Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

R M JavierRheumatology University Hospital Strasbourg, GRIO Groupe de Recherche Et d'Information Sur Les Ostéoporoses, Strasbourg, France.ORCID 0000-0002-3438-3543
F DebiaisDepartment of Rheumatology, University-Hospital of Poitiers, Poitiers, France.
F Alliot-LaunoisAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
D PoivretCHU Metz Mercy, AFLAR, Metz, France.
P BosgiraudAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
F BarbeAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
M BouyssiéAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
M DevertAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
F RouxAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
M P SacchiAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
S SirotAFLAR Association Française de Lutte Anti-Rhumatismale, Paris, France.
P HalboutIOF International Osteoporosis Foundation, Nyon, Switzerland.
T ChevalleyIOF International Osteoporosis Foundation, Nyon, Switzerland. thierry.chevalley@unige.ch.ORCID 0000-0003-3338-1148
J Y ReginsterIOF International Osteoporosis Foundation, Nyon, Switzerland.ORCID 0000-0001-6290-752X
B CortetDepartment of Rheumatology and ULR 4490 (MabLab), University-Hospital of Lille, Lille, France.ORCID 0000-0001-8912-0452

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of osteoporosis even after a fracture is declining. Our pilot study in patients with osteoporosis confirms a large ignorance of the disease and major fears and uncertainties about the treatments. Complete and sustained medical information seems essential to counteract the contradictory information, which are exclusively negative. PURPOSE: The management of osteoporosis (OP) even after a fracture has declined over recent years despite the actions of the medical societies concerned with this disease. The objective of this pilot study was to investigate patients' perceptions of OP, their treatment pathways, and how information is obtained.

methodsThe Association Française de Lutte Anti-Rhumatismale (AFLAR) constituted an advisory group of 7 French patients (mean age 63.7 years [54-74 years]), with various stages of OP and duration of disease. A qualitative, anonymized study was conducted with an open-ended semi-structured questionnaire, with a contribution of the International Osteoporosis Foundation (IOF) and the "Groupe de Recherche et Informations sur les Ostéoporoses" (GRIO).

resultsThe onset of OP was often sudden, with the fracture occurring in a context of deep misunderstanding of OP by both the public and physicians. The patients have confidence in the physician, mostly a rheumatologist, who informs about OP and initiates the treatment. The main cause of non-adherence being major fears and uncertainties about efficacy and safety of treatments. Medical information is considered as insufficient, or poorly understood. Negative information has the highest impact, even if the sources seem unreliable, such as media. There is no trust in pharmaceutical companies and the ethics of physicians are in question.

conclusionThis IOF/GRIO/AFLAR Patient Advisory Group pilot study illustrates the numerous barriers to effective OP management. Complete and sustained medical information, especially at the time of diagnosis and initiation of treatment, seems essential to counteract the contradictory information, which are exclusively negative.

Indexed as

Health Knowledge, Attitudes, PracticeOsteoporosisAgedBone Density Conservation AgentsFemaleHumansMaleMiddle AgedOsteoporotic FracturesPilot ProjectsQualitative ResearchSurveys and QuestionnairesBone Density Conservation AgentsAdverse eventsFractureOsteoporosis treatmentQuality of lifeTreatment adherence

Identifiers

PMID39812712
PMCPMC11735547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.